D’Angelo, D.; Quarta, E.; Glieca, S.; Varacca, G.; Flammini, L.; Bertoni, S.; Brandolini, M.; Sambri, V.; Grumiro, L.; Gatti, G.;
et al. An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics 2023, 15, 1023.
https://doi.org/10.3390/pharmaceutics15031023
AMA Style
D’Angelo D, Quarta E, Glieca S, Varacca G, Flammini L, Bertoni S, Brandolini M, Sambri V, Grumiro L, Gatti G,
et al. An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics. 2023; 15(3):1023.
https://doi.org/10.3390/pharmaceutics15031023
Chicago/Turabian Style
D’Angelo, Davide, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti,
and et al. 2023. "An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro" Pharmaceutics 15, no. 3: 1023.
https://doi.org/10.3390/pharmaceutics15031023
APA Style
D’Angelo, D., Quarta, E., Glieca, S., Varacca, G., Flammini, L., Bertoni, S., Brandolini, M., Sambri, V., Grumiro, L., Gatti, G., Dirani, G., Taddei, F., Bianchera, A., Sonvico, F., Bettini, R., & Buttini, F.
(2023). An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics, 15(3), 1023.
https://doi.org/10.3390/pharmaceutics15031023